Other established cancer therapeutics, such as temozolomide and tamoxifen, likewise are ineffective against tumor cells expressing TP53 GOF mutants due to specific effects of mutant p53 on O6-methylguanine DNA-methyltransferase (MGMT) and estrogen receptor expression, respectively [31]. This evidence concerns the gene ESR1 and cancer.